These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 20556771)
1. Bone morphogenetic protein (BMP) for fracture healing in adults. Garrison KR; Shemilt I; Donell S; Ryder JJ; Mugford M; Harvey I; Song F; Alt V Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD006950. PubMed ID: 20556771 [TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Garrison KR; Donell S; Ryder J; Shemilt I; Mugford M; Harvey I; Song F Health Technol Assess; 2007 Aug; 11(30):1-150, iii-iv. PubMed ID: 17669279 [TBL] [Abstract][Full Text] [Related]
3. Cochrane corner: bone morphogenetic protein (BMP) for fracture healing in adults. Glass GE; Jain A J Hand Surg Eur Vol; 2013 May; 38(4):447-9. PubMed ID: 23612734 [TBL] [Abstract][Full Text] [Related]
4. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7. Dahabreh Z; Dimitriou R; Giannoudis PV Injury; 2007 Mar; 38(3):371-7. PubMed ID: 17070526 [TBL] [Abstract][Full Text] [Related]
5. A health economic analysis of the use of rhBMP-2 in Gustilo-Anderson grade III open tibial fractures for the UK, Germany, and France. Alt V; Donell ST; Chhabra A; Bentley A; Eicher A; Schnettler R Injury; 2009 Dec; 40(12):1269-75. PubMed ID: 19539926 [TBL] [Abstract][Full Text] [Related]
6. Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: the German model. Alt V; Heissel A Curr Med Res Opin; 2006; 22 Suppl 1():S19-22. PubMed ID: 16882366 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the clinical effectiveness of Bone Morphogenic Protein (BMP) -2 and -7 in the adjunct treatment of lower limb nonunions. Haubruck P; Tanner MC; Vlachopoulos W; Hagelskamp S; Miska M; Ober J; Fischer C; Schmidmaier G Orthop Traumatol Surg Res; 2018 Dec; 104(8):1241-1248. PubMed ID: 30293748 [TBL] [Abstract][Full Text] [Related]
8. [Cost-benefit analysis of the use of rhBMP-2 in open tibial fractures: savings from a health insurer's perspective]. Alt V; Eicher A; Bitschnau A; Schnettler R Unfallchirurg; 2006 Jun; 109(6):463-70. PubMed ID: 16773321 [TBL] [Abstract][Full Text] [Related]
9. Bone Morphogenetic Protein for the Healing of Tibial Fracture: A Meta-Analysis of Randomized Controlled Trials. Dai J; Li L; Jiang C; Wang C; Chen H; Chai Y PLoS One; 2015; 10(10):e0141670. PubMed ID: 26509264 [TBL] [Abstract][Full Text] [Related]
10. Ultrasound and shockwave therapy for acute fractures in adults. Griffin XL; Parsons N; Costa ML; Metcalfe D Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008579. PubMed ID: 24956457 [TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic proteins in open fractures: past, present, and future. Nauth A; Ristiniemi J; McKee MD; Schemitsch EH Injury; 2009 Dec; 40 Suppl 3():S27-31. PubMed ID: 20082787 [TBL] [Abstract][Full Text] [Related]
12. A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7. Dahabreh Z; Calori GM; Kanakaris NK; Nikolaou VS; Giannoudis PV Int Orthop; 2009 Oct; 33(5):1407-14. PubMed ID: 19052743 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human bone morphogenetic protein-2 use in the off-label treatment of nonunions and acute fractures: a retrospective review. Starman JS; Bosse MJ; Cates CA; Norton HJ J Trauma Acute Care Surg; 2012 Mar; 72(3):676-81. PubMed ID: 22491552 [TBL] [Abstract][Full Text] [Related]
19. RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation. Ristiniemi J; Flinkkilä T; Hyvönen P; Lakovaara M; Pakarinen H; Jalovaara P J Bone Joint Surg Br; 2007 Feb; 89(2):265-72. PubMed ID: 17322450 [TBL] [Abstract][Full Text] [Related]
20. Bone graft substitutes for the treatment of traumatic fractures of the extremities. Hagen A; Gorenoi V; Schönermark MP GMS Health Technol Assess; 2012; 8():Doc04. PubMed ID: 22984371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]